Results 11 to 20 of about 629,305 (401)

Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution

Medical Science Monitor, 2023
The 2023 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report includes relevant topics from the clinician’s perspective and evidence published on chronic obstructive pulmonary disease (COPD) since GOLD 2017. The World Health Organization (
D. Parums
semanticscholar   +1 more source

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study

International Journal of COPD, 2022
Background Studies have shown that chronic obstructive pulmonary disease (COPD) exacerbation events are related to future events; however, previous literature typically reports frequent vs infrequent exacerbations per patient-year and no studies have ...
H. Whittaker, A. Rubino, H. Müllerová, T. Morris, P. Varghese, Yang Xu, E. de Nigris, J. Quint   +7 more
semanticscholar   +1 more source

Pathological Mechanism and Targeted Drugs of COPD

International Journal of COPD, 2022
Chronic obstructive pulmonary disease (COPD) includes chronic bronchitis, emphysema, and small airway obstruction. Incompletely reversible airflow limitation, inflammation, excessive mucus secretion and bronchial mucosal epithelial lesions are the main ...
Peng Guo, Rui Li, Tie Hua Piao, Chunhua Wang, Xiao Wu, Hongzhou Cai   +5 more
semanticscholar   +1 more source

Gut microbiota modulates COPD pathogenesis: role of anti-inflammatory Parabacteroides goldsteinii lipopolysaccharide

Gut, 2021
Objective Chronic obstructive pulmonary disease (COPD) is a global disease characterised by chronic obstruction of lung airflow interfering with normal breathing. Although the microbiota of respiratory tract is established to be associated with COPD, the
H. Lai, Tzu-Lung Lin, Ting-Wen Chen, Y. Kuo, Chih-Jung Chang, Tsung-Ru Wu, C. Shu, Ying-Huang Tsai, S. Swift, Chia-Chen Lu   +9 more
semanticscholar   +1 more source

Prevalence, Severity and Mortality associated with COPD and Smoking in patients with COVID-19: A Rapid Systematic Review and Meta-Analysis

medRxiv, 2020
Background: Coronavirus disease 2019 (COVID-19) is an evolving infectious disease that dramatically spread all over the world in the early part of 2020.
J. Alqahtani, Tope Oyelade, A. Aldhahir, S. Alghamdi, M. Almehmadi, A. Alqahtani, S. Quaderi, S. Mandal, J. Hurst   +8 more
semanticscholar   +1 more source

ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

European Respiratory Journal, 2020
The World Health Organization (WHO) has declared coronavirus disease 2019 (COVID-19) a pandemic [1]. COVID-19 is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
J. Leung, C. Yang, A. Tam, T. Shaipanich, T. Hackett, G. Singhera, D. Dorscheid, D. Sin   +7 more
semanticscholar   +1 more source

Comorbidities of COPD [PDF]

European Respiratory Review, 2013
By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality. Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco smoking is a common risk factor for many comorbidities, including coronary heart disease, heart failure and lung cancer.
Cavaillès, Arnaud, Brinchault-Rabin, Graziella, Dixmier, Adrien, Goupil, François, Gut-Gobert, Christophe, Marchand-Adam, Sylvain, Meurice, Jean-Claude, Morel, Hugues, Person-Tacnet, Christine, Leroyer, Christophe, Diot, Patrice   +10 more
openaire   +5 more sources

Economic Burden of Chronic Obstructive Pulmonary Disease (COPD): A Systematic Literature Review

International Journal of COPD, 2020
Background and Objectives Chronic obstructive pulmonary disease (COPD) affects over 250 million people globally, carrying a notable economic burden. This systematic literature review aimed to highlight the economic burden associated with moderate-to-very
I. Iheanacho, Shiyuan Zhang, D. King, M. Rizzo, A. Ismaila   +4 more
semanticscholar   +1 more source

Treatments for COPD [PDF]

Respiratory Medicine, 2005
The multicomponent nature of chronic obstructive pulmonary disease (COPD) has provided a challenging environment in which to develop successful treatments. A combination of pharmacological and non-pharmacological approaches is used to combat this problem, and an overview of these approaches and their possible future direction is given.
Hanania, Nicola A., Ambrosino, Nicolino, Calverley, Peter, Cazzola, Mario, Donner, Claudio F, Make, Barry   +5 more
openaire   +3 more sources

Women's COPD [PDF]

Frontiers in Medicine, 2022
Chronic obstructive pulmonary disease (COPD) is no longer a respiratory disease that predominantly affects men, to the point where the prevalence among women has equaled that of men since 2008, partly due to their increasing exposure to tobacco and to biomass fuels. Indeed, COPD has become the leading cause of death in women in the USA.
Maéva Zysman, Maéva Zysman, Chantal Raherison-Semjen, Chantal Raherison-Semjen   +3 more
openaire   +4 more sources